Survival by dialysis modality in critically ill patients with acute kidney injury

被引:73
作者
Cho, Kerry C.
Himmelfarb, Jonathan
Paganini, Emil
Ikizler, T. Alp
Soroko, Sharon H.
Mehta, Ravindra L.
Chertow, Glenn M.
机构
[1] Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA 94143 USA
[2] Maine Med Ctr, Dept Med, Div Nephrol, Portland, ME 04102 USA
[3] Cleveland Clin Fdn, Dept Med, Div Nephrol, Cleveland, OH 44195 USA
[4] Vanderbilt Univ, Dept Med, Div Nephrol, Nashville, TN USA
[5] Univ Calif San Diego, Dept Med, Div Nephrol, San Diego, CA 92103 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2006年 / 17卷 / 11期
关键词
D O I
10.1681/ASN.2006030268
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Among critically ill patients, acute kidney injury (AKI) requiring dialysis is associated with mortality rates generally in excess of 50%. Continuous renal replacement therapies (CRRT) often are recommended and widely used, although data to support its superiority over intermittent hemodialysis (IHD) are lacking. Data from the Program to Improve Care in Acute Renal Disease (PICARD), a multicenter observational study of AKI, were analyzed. Among 398 patients who required dialysis, the risk for death within 60 d was examined by assigned initial dialysis modality (CRRT [n = 206] versus IHD [n = 1921) using standard Kaplan-Meier product limit estimates, proportional hazards ("Cox") regression methods, and a propensity score approach to account for selection effects. Crude survival rates were lower for patients who were treated with CRRT than IHD (survival at 30 d 45 versus 58%; P = 0.006). Adjusted for age, hepatic failure, sepsis, thrombocytopenia, blood urea nitrogen, and serum creatinine and stratified by site, the relative risk for death associated with CRRT was 1.82 (95% confidence interval 1.26 to 2.62). Further adjustment for the propensity score did not materially alter the association (relative risk 1.92; 95% confidence interval 1.28 to 2.89). Among critically ill patients with AKI, CRRT was associated with increased mortality. Although the results could reflect residual confounding by severity of illness, these data provide no evidence for a survival benefit afforded by CRRT. Larger, prospective, randomized clinical trials to compare CRRT and IHD in severe AKI are needed.
引用
收藏
页码:3132 / 3138
页数:7
相关论文
共 44 条
[1]   A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF [J].
Augustine, JJ ;
Sandy, D ;
Seifert, TH ;
Paganini, EP .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (06) :1000-1007
[2]   Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: A prospective, randomized trial [J].
Bouman, CSC ;
Oudemans-van Straaten, HM ;
Tijssen, JGP ;
Zandstra, DF ;
Kesecioglu, J .
CRITICAL CARE MEDICINE, 2002, 30 (10) :2205-2211
[3]   Continuous venovenous hemodiafiltration versus hemodialysis as renal replacement therapy in patients with acute renal failure in the intensive care unit [J].
Chang, JW ;
Yang, WS ;
Seo, JW ;
Lee, JS ;
Lee, SK ;
Park, SK .
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2004, 38 (05) :417-421
[4]   Mortality after acute renal failure: Models for prognostic stratification and risk adjustment [J].
Chertow, G. M. ;
Soroko, S. H. ;
Paganini, E. P. ;
Cho, K. C. ;
Himmelfarb, J. ;
Ikizler, T. A. ;
Mehta, R. L. .
KIDNEY INTERNATIONAL, 2006, 70 (06) :1120-1126
[5]   Reasons for non-enrollment in a cohort study of ARF: The program to improve care in acute renal disease (PICARD) experience and implications for a clinical trials network [J].
Chertow, GM ;
Pascual, MT ;
Soroko, S ;
Savage, BR ;
Himmelfarb, J ;
Ikizler, TA ;
Paganini, EP ;
Mehta, RL .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (03) :507-512
[6]   Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? [J].
Chertow, GM ;
Sayegh, MH ;
Allgren, RL ;
Lazarus, JM .
AMERICAN JOURNAL OF MEDICINE, 1996, 101 (01) :49-53
[7]  
CLARK WR, 1994, J AM SOC NEPHROL, V4, P1413
[8]   A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure [J].
Cohn, JN ;
Goldstein, SO ;
Greenberg, BH ;
Lorell, BH ;
Bourge, RC ;
Jaski, BE ;
Gottlieb, SO ;
McGrew, F ;
DeMets, DL ;
White, BG .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (25) :1810-1816
[9]   The effectiveness of right heart catheterization in the initial care of critically ill patients [J].
Connors, AF ;
Speroff, T ;
Dawson, NV ;
Thomas, C ;
Harrell, FE ;
Wagner, D ;
Desbiens, N ;
Goldman, L ;
Wu, AW ;
Califf, RM ;
Fulkerson, WJ ;
Vidaillet, H ;
Broste, S ;
Bellamy, P ;
Lynn, J ;
Knaus, WA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (11) :889-897
[10]  
COX DR, 1972, J R STAT SOC B, V34, P187